OpenAlex
PricingAboutJobs
Log inGet started
Work

A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.

PubMed

Year: 2000
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: R D Alvarez, M N Barnes, J Gomez-Navarro, M Wang, T V Strong, W Arafat, R B Arani, M R Johnson, B L Roberts, G P Siegal, D T Curiel
Institution: University of Alabama at Birmingham
Language: English

Topic: Virus-based gene therapy research
Subfield: Genetics
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: gene therapy, adenoviral vector, intrabodies, ovarian cancer, recurrent ovarian cancer, intraperitoneal administration, vector toxicity, CA125
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Awards: GENE THERAPY FOR OVARIAN CANCER, SFV MEDIATED ONCOGENE KNOCKOUT FOR CHEMOSENSITIZATION, SINGLE CHAIN GENE THERAPY OF OVARIAN CANCER
OpenAlex ID: W2144674318
FWCI: 7.001
Cites: 30
Cited by: 181
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms